Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Pharmaceutical Research Network |
---|---|
Information provided by: | Pharmaceutical Research Network |
ClinicalTrials.gov Identifier: | NCT00273455 |
To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy
Condition | Intervention | Phase |
---|---|---|
Open-Angle Glaucoma |
Drug: bimatoprost 0.03% Drug: dorzolamide 2%/timolol maleate 0.5% fixed combination Drug: placebo |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Crossover Assignment |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Kentucky | |
Taustine Eye Center | |
Louisville, Kentucky, United States, 40217 | |
United States, South Carolina | |
Glaucoma Consultants & Center for Eye Research, PA | |
Mt. Pleasant, South Carolina, United States, 29464 | |
United States, Texas | |
Houston Eye Associates | |
Houston, Texas, United States, 77025 |
Study Director: | William C. Stewart, MD | Pharmaceutical Research Network, LLC |
Principal Investigator: | Robert D. Williams, MD | Taustine Eye Center |
Principal Investigator: | Robert H. Stewart, MD | Houston Eye Associates |
Principal Investigator: | Elizabeth D. Sharpe, MD | Glaucoma Consultants & Center for Eye Research, PA |
Study ID Numbers: | PRN 05-017 |
Study First Received: | January 6, 2006 |
Last Updated: | November 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00273455 |
Health Authority: | United States: Institutional Review Board |
Bimatoprost Glaucoma Eye Diseases Glaucoma, Open-Angle |
Timolol Dorzolamide Hypertension Ocular Hypertension |
Neurotransmitter Agents Adrenergic Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Enzyme Inhibitors Cardiovascular Agents Antihypertensive Agents |
Pharmacologic Actions Carbonic Anhydrase Inhibitors Therapeutic Uses Adrenergic beta-Antagonists Adrenergic Antagonists Anti-Arrhythmia Agents |